Biocytogen inks non-exclusive VHH antibody licensing deal with Qilu Pharma
Biocytogen Pharmaceuticals (Beijing) entered a non-exclusive licensing agreement with Qilu Pharmaceutical covering a fully human VHH antibody molecule.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.